Skip to main content
Have a personal or library account? Click to login
Cognitive Outcome of Acth-Treated Infantile Spasms Cover

Cognitive Outcome of Acth-Treated Infantile Spasms

Open Access
|Mar 2004

Abstract

The long-term cognitive and seizure outcomes of 37 patients with cryptogenic infantile spasms (onset, age 3 to 9 months) treated with high-dose synthetic adrenocorticotropic hormone (ACTH) (1 mg IM every 48 hrs for 2 weeks, 8-10-week slow taper, followed by oral prednisone, 10 mg/d for 1 month, and slow taper for 5 months or until age 1 year) were evaluated at Schneider Children’s Medical Center of Israel, Petah Tiqva, Israel.
Language: English
Page range: 20 - 21
Published on: Mar 1, 2004
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services

© 2004 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.